Mechanisms of drug-induced liver injury: from bedside to bench (Q34169362)

31 July 2017

1 reference

title

Mechanisms of drug-induced liver injury: from bedside to bench (English)

1 reference

31 July 2017

Shannan Tujios

1

1 reference

31 July 2017

Robert J. Fontana

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21386809

26 November 2024

language of work or name

English

0 references

publication date

8 March 2011

1 reference

full work available at URL

31 July 2017

http://www.nature.com/articles/nrgastro.2011.22.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

http://www.nature.com/articles/nrgastro.2011.22

26 November 2024

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Nature Reviews Gastroenterology & Hepatology

26 November 2024

published in

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

202-211

1 reference

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Important elements for the diagnosis of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Molecular mechanisms of the hepatotoxicity caused by acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

The complex interaction between ethanol and acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Measurement of serum acetaminophen-protein adducts in patients with acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Critical role of CD44 in hepatotoxin-mediated liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Idiosyncratic drug reactions: current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Case series of liver failure associated with rosiglitazone and pioglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Role of metabolism in drug-induced idiosyncratic hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Immunoallergic drug-induced liver injury in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Drug-induced liver injury: mechanisms and test systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Role of mitochondria in drug-induced cholestatic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in japanese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

The pathology of cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Liver disease associated with canalicular transport defects: current and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Hepatobiliary transporters and drug-induced cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Drug-induced liver injury: summary of a single topic clinical research conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: Model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Biomarkers for the diagnosis and management of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

HLA association of amoxicillin-clavulanate--induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

A role for the pregnane X receptor in flucloxacillin-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Drug-induced liver injury following positive drug rechallenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

The lymphocyte transformation test in the diagnosis of drug hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Hy's law: predicting serious hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

31 March 2020

Drug-induced cholestasis

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo

31 March 2020

1 reference

12 December 2020

Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism

1 reference

12 December 2020

HLA-B*5701 screening for hypersensitivity to abacavir

1 reference

12 December 2020

The management of anti-tuberculosis drug-induced hepatotoxicity.

1 reference

12 December 2020

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.

1 reference

12 December 2020

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period

1 reference

12 December 2020

Roles of CD44 in chemical-induced liver injury

1 reference

12 December 2020

Journal of Pharmacology and Experimental Therapeutics

14

187

185

JR Mitchell

1973

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2011.22

26 November 2024

Identifiers

1 reference

31 July 2017

1 reference